Aged Garlic Extract Reduces IL-6: A Double-Blind Placebo-Controlled Trial in Females with a Low Risk of Cardiovascular Disease.
Martiné WlosinskaAnn-Christin NilssonJoanna HlebowiczMohammed FakhroMalin MalmsjöSandra LindstedtPublished in: Evidence-based complementary and alternative medicine : eCAM (2021)
The present study concludes that AGE lowers IL-6 in females with a risk profile of cardiovascular disease. We could also conclude that risk prediction with cardiac CT scan turned out to be superior in estimating the risk of cardiac disease compared to Framingham risk score. This trial is registered with NCT03860350.